Ekbom
The headaches occur with remarkable regularity and at night are related to REM sleep (Dexter, 1970) . Sandler (1974) Ergotamine provided relief so long as it was taken at the first sign ofa headache, buthe becamefrightened ofthis medication, particularly when having to take 20 or more tablets a week. He viewed ergotamine as a symptomatic measure and felt the problem would return the following day. Methysergide provided only mild relief, and Mr H. discontinued it after a month. Propranolol was taken for a month without significant effect, and biofeedback had no effect.
Lithium carbonate was introduced at 300 mg twice a day (serum level 0.34 mEq/L) with no response. However, began to return and progressed in severity and frequency until reaching a state similar to that before the initiation of lithium. The imipramine was discontinued, but despite manipulations of the lithium dosage the headaches could not be brought back under control and the patient left treatment.
After an interval of six months, MA. returned and requested a second trial of lithium. His headache fre quency was again one every three hours. Within six days of the reinstitution of lithium (900 mg, serum level 0.9 mEq/L), there was a dramatic decline in headache frequency to one headache a day or every other day. This has continued up to the time of writing (15 months).
Comments
For the purposes of the following discussion we will assume that migraine and cluster headaches share a similar if not identical pathophysiology, although we recognize that there is abundant controversy attached to this. Herberg (1975) found to be effective in migraine prophylaxis (Couch, 1974 (Couch, , 1976 , it is possible that M.A.'s relapse was due to the imipramine-lithium combination.
Tricyclic antidepressants, monoamine oxidase inhibitors and lithium carbonate have all been shown to be effective for some patients with vascular headaches (Ekbom, 1977; Couch, 1974 Couch, , 1976 Anthony, 1969) . There is evidence that these drugs alter MAO activity (Sandler, 1974; Glover, 1977; Bockar, 1974; Sullivan, 1977) . As a transitory decrease in platelet MAO activity has been demonstrated during migraine attacks (Glover, 1977) 
